AGM/EGMApr 27, 2026, 04:14 PM
ALDX 2026 Annual Meeting Set for June 9; Director Election, Auditor Ratification
AI Summary
Aldeyra Therapeutics, Inc. announced its 2026 Annual Meeting of Stockholders will be held on Tuesday, June 9, 2026, at 9:00 a.m. local time in Boston. Stockholders of record as of April 13, 2026, are entitled to vote on three key proposals. These include the election of Todd C. Brady, M.D., Ph.D. as a Class III director, the ratification of BDO USA, P.C. as the independent registered public accounting firm for 2026, and an advisory vote on executive compensation. Additionally, Martin J. Joyce will not seek re-election, leading to a reduction in the board's size.
Key Highlights
- ALDX to hold 2026 Annual Meeting of Stockholders on June 9, 2026, at 9:00 a.m. local time.
- Stockholders of record as of April 13, 2026, are eligible to vote.
- Proposal 1: Elect Todd C. Brady, M.D., Ph.D. as Class III director until 2029.
- Proposal 2: Ratify BDO USA, P.C. as independent auditor for year ending December 31, 2026.
- Proposal 3: Advisory vote on named executive officer compensation.
- Martin J. Joyce will not stand for re-election, reducing board size to seven members.
- Proxy materials and 2025 Annual Report available at www.proxyvote.com.
Price Impact
More from ALDX